Admit Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.91 M
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.45 M
- Revenue Growth -63.31%
- Profit Growth -73.53%
- Ebitda -97.21%
- Net Worth 1.26%
- Total Assets 2.60%
About Admit Pharmaceuticals
Admit Pharmaceuticals Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 March 2005 and has a history of 19 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.91 M.
The company has closed loans amounting to ₹5.45 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Mehul Katariya and Mahesh Paradava serve as directors at the Company.
Company Details
-
Location
Ahmedabad, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230GJ2005PTC045758
-
Company No.
045758
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
24 Mar 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Admit Pharmaceuticals Private Limited offer?
Admit Pharmaceuticals Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Hormones and Steroid API, Steam Cleaners, Antimigraine Drug, Zolmitriptan Nasal Spray, Cleaning Machines & Equipments.
Who are the key members and board of directors at Admit Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mehul Katariya
|
Director | 28-Mar-2013 | Current |
|
Mahesh Paradava
|
Director | 25-Jul-2015 | Current |
Financial Performance of Admit Pharmaceuticals.
Admit Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 63.31% decrease. The company also saw a substantial fall in profitability, with a 73.53% decrease in profit. The company's net worth moved up by a moderate rise of 1.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Admit Pharmaceuticals?
In 2018, Admit Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0
₹5.45 M
Charges Breakdown by Lending Institutions
- Indian Bank : 0.22 Cr
- Vijay Commercialco-Operative Bank Limited : 0.20 Cr
- Vijay Commercial Co-Operative Bank Limited : 0.13 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jul 2010 | Indian Bank | ₹2.20 M | Satisfied |
| 25 Mar 2009 | Vijay Commercialco-Operative Bank Limited | ₹2.00 M | Satisfied |
| 11 May 2006 | Vijay Commercial Co-Operative Bank Limited | ₹1.25 M | Satisfied |
How Many Employees Work at Admit Pharmaceuticals?
Unlock and access historical data on people associated with Admit Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Admit Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Admit Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
